Intraperitoneal Ropivacaine Irrigation in Bariatric Surgery

• Status: Completed
• Trial end date: 2015-12-01
• Target enrollment: 0
• Participant gender: All

Summary

A prospective randomized clinical trial of all the patients undergoing laparoscopic sleeve gastrectomy (LSG) or laparoscopic Roux-en-Y gastric bypass (LRYGB) will be performed. Patients will be randomized in 2 groups: those patients undergoing intraperitoneal ropivacaine irrigation (Experimental Group - EG) and those undergoing intraperitoneal irrigation with normal saline (Control Group - CG).

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hospital General Universitario Elche
• Treatments: Ropivacaine

Criteria

Inclusion Criteria:

• Body mass index (BMI) >40 Kg/m2

• BMI > 35 Kg/m2 with the presence of comorbidities associated to obesity.

Exclusion Criteria:

• patients undergoing other bariatric techniques or revisional surgery

• allergy to local anesthetics

• severe underlying cardiovascular diseases

• chronic renal failure

• hepatic dysfunction

• previous foregut surgery

• patients with any contraindication for bariatric surgery.